Abstract
This is a review of the common chromosome and genetic disorders associated with male infertility that need to be considered by the clinician and the couple in the context of treatment. Until recently the most relevant disorders have been those inherited from parents, however, with the advent of technologies enabling recovery of sperm from the testicle in men with severely damaged spermatogenesis there is increased interest in those genetic abnormalities that may occur in mitosis and meioses. It is likely that over the next ten years there will be increasing focus on this aspect of male fertility genetic disorders. This article needs to be read in conjunction with the specific in depth reviews in this journal edition.
Similar content being viewed by others
References
Lewis S.E. Life cycle of the mammalian germ cell: Implication for spontaneous mutation frequencies. Teratology 1999, 59: 205–209.
Saffman E.E., Lasko P. Germline development in vertebrates and invertebrates. Cell. Mol. Life Sci. 1999, 55: 1141–1163.
Persson J.W. A hypothesis on the origin of germ cell mutation and evolutionary role of extra embryonic mutation. Hum. Reprod. 1999: 1840–1841.
Simmerly C., Wu G.J., Zoran S., Ord T., Rawlins R., Jones J., Navara C., Gerrity M., Rinehart J., Binor Z., Asch R., et al. The paternal inheritance of the centrosome, the cells microtubular organizing center in humans and the implications for infertility. Nat. Med. 1995, 1: 47–52.
Van-Assche E., Bonduelle M., Tournaye H., Joris H., Verheyen G., Devroey P., Steirteghem A.V., Liebaers I. Cytogenetics of infertile men. Hum. Reprod. (Suppl. 4) 1996, 11: 1–24.
Johnson M.D. Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening. Fertil. Steril. 1998, 70: 397–411.
Peschka B., Leygraaf J., van der Ven K., Montag M., Schartmann B., Schubert R., van der Ven H., Schwanitz R. Type and frequency of chromosome aberrations in 781 couple undergoing intracytoplasmic sperm injection. Hum. Reprod. 1999, 14: 2257–2263.
De-Braekeleer M., Dao T.N. Cytogenetic studies in male infertility: a review. Hum. Reprod. 1991, 6: 245–250.
Okada H., Fujioka H., Tatsumi N., Kanzaki M., Okuda Y., Fujisawa M., Hazama M., Matsumoto O., Gohji K., Arakawa S., Kamidono S. Klinefelter’s syndrome in the male infertility clinic. Hum. Reprod. 1999, 14: 946–952.
Tournaye H., Staessen C., Liebaers I., Assche E.V., Devroey P., Bonduelle M., Steirteghem A.V. Testicular sperm recovery in nine 47 XXY Klinefelter patients. Hum. Reprod. 1996, 11: 1644–1649.
Wang C., Baker H.W.G., Burger H.G., De Kretser D.M., Hudson B. Hormonal studies in men with Klinefelter’s syndrome. Clin. Endocrinol. (Oxf.) 1975, 4: 399–414.
Chevret E., Rousseaux S., Monteil M. Increased incidence of hyperhaploid 24 XY spermatozoa detected by three-colour FISH in a 46XY/ 47XXY male. Hum. Genet. 1996, 97: 171–175.
Martini E., Geraedts J.P.M., Liebaers I., Land J.A., Capitanio G.L., Ramaekers F.C.S., Hopman A.H.N. Constitution of semen samples from XYY and XXY males as analysed by in-situ hybridization. Hum. Reprod. 1996, 11: 1638–1643.
Cozzi J., Chevret E., Rousseaux S. Achievement of meiosis in XXY germ cells: study of 543 sperm karyotypes from an XY/XXY mosaic patient. Hum. Genet. 1994, 93: 32–34.
Estop A.M., Munne S., Cieply K.M., Vandermark K.K., Lamb A.N., Fisch H. Meiotic products of a Klinefelter 47,XXY male as determined by sperm fluorescence in-situ hybridization analysis. Hum. Reprod. 1998, 13: 124–127.
Foresta C., Galeazzi C., Bettella A., Stella M., Scandellari C. High incidence of sperm sex chromosomes aneuploidies in two patients with Klinefelter’s syndrome. J. Clin. Endocrinol. Metab. 1998, 83: 203–205.
Guttenbach M., Michelmann H.W., Hinney B., Engel W., Schmid M. Segregation of sex chromosomes into sperm nuclei in a man with 47,XXY Klinefelter’s karyotype: a FISH analysis. Hum. Genet. 1997, 99: 474–477.
Hennebicq S., Pelletier R., Rousseaux S., Sele B. Segregation of sex chromosomes in a Klinefelter patient (47,XXY). 15th Annual Meeting of the ESHRE. Abstract book 1. Hum. Reprod. 1999, 14: 66.
Persson J.W., Peter G.B., Saunders D.M. Is ICSI associated with risks of genetic disease? Implications for counselling, practice and research. Hum. Reprod. 1996, 11: 921–924.
Chevret E.R.S., Monteil M., Usson Y., Cozzi J., Pelletier R., Sele B. Meiotic behaviour of sex chromosomes investigated by three-colour FISH on 35142 sperm nuclei from two 47,XYY males. Hum. Genet. 1997, 99: 407–412.
Chandley A.C., Edmond P.E., Christie S., Gowans I., Fletcher J., Frackiewicz A., Newton M. Cytogenetics and infertility in man. Results of a five year study of men attending a subfertility clinic. Ann. Hum. Genet. 1975, 39: 231–254.
Moog U., Coonen E., Dumoulin J.C.M., Engelen J.J.M. Karyotypes of men involved in ICSI programmes: the Maastricht experience, April 1994 to date. 12th Annual Meeting of the EHSRE, Maastricht, 1996. Hum. Reprod. 1996, 11: 223.
Bowles J.T. The evolution of aging: a new approach to an old problem of biology. Med. Hypotheses 1998, 51: 179–221.
Franco B., Guioli S., Pragliola A., Incerti B., Bardoni B., Tonlorenzi R., Carrozzo R., Maestrini E., Pieretti M., Taillon-Miller P. A gene deleted in Kallmann’s syndrome shares homology with neural cell adhesion and axonal pathfinding molecules. Nature 1991, 353: 529–536.
Sauten R.J., Paulsen C.A. Hypogonadotrophic Eunuchoidism. I. Clinical study of the mode of inheritance. J. Clin. Endocrinol. Metab. 1973, 36: 47–54.
Tincello D.G., Saunders P.T.K., Hargreave T.B. Preliminary investigations on androgen receptor gene mutations in infertile men. Mol. Hum. Reprod. 1997, 3: 941–943.
Wennerholm U-B., Bergh C., Hamberger L., Lundin K., Nilsson L., Wikland M., Kallen B. Incidence of congenital malformations in children born after ICSI. Hum. Reprod. 2000, 15: 944–948.
Dowsing A.T., Yong E.L., Clark M., McLachlan R.I., De-Kretser D.M., Trounson A.O. Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 1999: 640–643.
Vogt P.H. Risk of neurodegenerative diseases in children by intracytoplasmic sperm injection? Lancet 1999, 354: 611–612.
Ma K., Sharkey A., Kirsch S., Vogt P., Keil R., Hargreave T.B., McBeath S., Chandley A.C. Towards the molecular localisation of the AZF locus: mapping of microdeletions in azoospermic men within 14 subintervals of interval 6 of the human Y chromosome. Hum. Mol. Genet. 1992, 1: 29–33.
Vogt P., Chandley A.C., Hargreave T.B., Keil R., Ma K., Sharkey A. Microdeletions in interval 6 of the Y chromosome of males with idiopathic sterility point to disruption of AZ, a human spermatogenesis gene. Hum. Genet. 1992, 89: 491–496.
Mallidis C., Loveland K., Najmabadi H., McLaughlin R., Baker G., Bhasin S., De-Kretser D.M. The incidence the deleted azoospermia gene in infertile men. 12th Annual Meeting, Maastricht 1996. Hum. Reprod. 1996, 11: 56–57.
Kent-First M., Muallem A. Development of a large highly diagnostic panel of multiplexed sequence tagged sites (STS’S) which cover key regions on human Yq: its application in fertile and infertile (azoospermic and oligozoospermic) populations. In: Proceedings of the Second International Workshop on the Y Chromosome. Organised by the National Institutes of Health USA and Human Genome Organisation, Medical Research Council, UK. Asilomar Conference Centre, Pacific Grove, California, Sept. 17–20, 1995, pp. 24–25.
Kupker W., Ludwig M., Hahn K., Al-Hasani S., Montzka P., Felberbaum R., Sturm R., Yilmaz A., Diedrich K. Prevalence of microdeletions in the azoospermia factor region of the Y chromosome in cases of azoospermia and severe oligoasthenoteratozoospermia. 12th Annual Meeting of the EHSRE, Maastricht 1996. Hum. Reprod. 1996, 11: 57.
Kobayashi K., Mizuno K., Hida A., Komaki R., Tomita K., Matsushita I., Namiki M., Iwamoto T., Tamura S., Minowada S., Nakahori Y., et al. PCR analysis of the Y chromosome long arm in azoospermic patients: evidence for a second locus required for spermatogenesis. Hum. Mol. Genet. 1994, 3: 1965–1967.
Najmabadi H., Huang V., Yen P., Subbarao M.N., Bhasin D., Banaag L., Naseeruddin S., De Kretser D.M., Baker H.W.G., McLachlan R.I., Loveland K.A., et al. Substantial prevalence of microdeletions of the Y chromosome in infertile men with idiopathic azoospermia and oligozoospermia detected using a sequence-tagged site-based mapping strategy. J. Clin. Endocrinol. Metab. 1996, 81: 1347–1352.
Reijo R., Alagappan P.K., Patrizio P., Page D.C. Severe oligozoospermia resulting from deletions of azoospermia factor gene on Y chromosome. Lancet 1996, 347: 1290–1293.
Qureshi S.J., Ross A.R., Ma K., Cooke H.J., McIntyre M.A., Hargreave T.B. Polymerase chain reaction screening for Y chromosome microdeletions: a first step towards the diagnosis of genetically determined spermatogenetic failure in men. Mol. Hum. Reprod. 1996, 2: 775–779.
Foresta C., Rassato M., Garolla A., Ferlin A. Male infertility and ICSI: are there any limits? Hum. Reprod. 1996, 11: 2347–2348.
Stuppia L., Mastroprimiano G., Calabrese G., Peila R., Tanaglia R., Palka G. Microdeletions in interval 6 of the Y chromosome detected by STS-PCR in 6 of 33 patients with idiopathic oligo- or azoospermia. Cytogenet Cell Genet. 1996, 72: 155–158.
Vogt P., Edelmann A., Kirsch S. Human Y-Chromosome azoospermic factors AZF mapped to different regions in Ya11. Hum. Mol. Genet. 1996, 5: 933–943.
Pryor J.L., Kent-First M., Muallem A., Van Bergen A.H., Nolten W.E., Meisner L., Roberts K.P. Microdeletions in the Y chromosome of infertile men. N. Engl. J. Med. 1997, 336: 534–539.
Foresta C., Ferlin A., Garolla A., Rossato M., Barbaux S., Debortoli A. Y-chromosome deletions in idiopathic severe testiculopathies. J. Clin. Endocrinol. Metab. 1997, 82: 1075–1080.
Simoni M., Gromoll J., Dwoniczak B., Rolf C., Abshagen K., Kamischke A., Carani C., Meschede D., Behre H.M., Horst J., Nieschlag E. Screening for deletions of the Y chromosome involving the DAZ (Deleted in Azoospermia) gene in azoospermia and severe oligozoospermia. Fertil. Steril. 1997, 67: 542–547.
Girardi S.K., Mielnik A., Schlegel P.N. Submicroscopic deletions in the Y chromosome of infertile men. Hum. Reprod. 1997, 12: 1635–1641.
Stuppia L., Gatta V., Calabrese G., Franchi P.G., Morizio E., Bombieri C., Mingarelli R., Sforza V., Frajese G., Tenaglia R., Palka G. A quarter of men with idiopathic oligo-azospermia display chromosomal abnormalities and microdeletions of different types in interval 6 of Yq11. Hum. Genet. 1998, 102: 566–570.
Krausz C., Bussani-Mastellone C., Granchi S., McElreavey K., Scarselli G., Forti G. Screening for microdeletions of Y chromosome genes in patients undergoing intracytoplasmic sperm injection. Hum. Reprod. 1999, 14: 1717–1721.
Kleiman S.E., Yogev L., Gamzu R., Hauser R., Botchan A., Lessing J.B., Paz G., Yavetz H. Genetic evaluation of infertile men. Hum. Reprod. 1999, 14: 33–38.
Kent-First M.G., Kol S., Maullem A., Blazer S., Itskovitz-Eldor J. Infertility in intracytoplasmic sperm injection-derived sons (Letter, comment). Lancet 1996, 348: 332.
Stuppia L., Gatta V., Mastroprimiano G. Clustering of Y chromosome deletions in subinterval E of interval 6 supports the existence of an oligozoospermia critical region outside the DAZ gene. J. Med. Genet. 1997, 34: 881–883.
Mulhall J.P., Reijo R., Alagappan R., Brown L., Page D., Carson R., Oates R.D. Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injection. Hum. Reprod. 1997, 12: 503–508.
Silber S.J., Alagappan R., Brown L.G., Page D.C. Y chromosome deletions in azoospermic and severely oligozoospermic men undergoing intracytoplasmic sperm injection after testicular sperm extraction. Hum. Reprod. 1998, 13: 3332–3337.
Kamischke A., Gromoll J., Simoni M., Behre H.M., Nieschlag E. Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDYI) genes from father to son through intracytoplasmic sperm injection. Hum. Reprod. 1999, 14: 2320–2322.
Kleiman S.E., Yogev L., Gamzu R., Hauser R., Botchan A., Paz G., Lessing J.B, Yaron Y., Yavetz H. Three-generation evaluation of Y-chromosome microdeletion. J. Androl. 1999, 20: 394–398.
Page D., Silber S., Brown L.G. Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperm injection, but are likely to transmit the deletion and infertility. Hum. Reprod. 1999, 14: 1722–1726.
Henegariu O., Hirschmann P., Killian K., Kirsch S., Lengauer C., Maiwald R., Mielke K., Vogt P. Rapid screening of the Y chromosome in idiopathic sterile men, diagnostic for deletions in AZF, a genetic Y factor expressed during spermatogenesis. Andrologia 1994, 26: 97–106.
Simoni M., Nieschlag E. Molecular diagnostics of Y chromosomal microdeletions: the international quality control programme of the European Academy of Andrology. 15th Annual Meeting of the ESHRE. Abstract book 1. Hum. Reprod. 1999, 14: 92–93.
Ferlin A., Moro E., Onisto M., Toscano E., Brettella A., Foresta C. Absence of testicular DAZ gene expression in idiopathic severe testiculopathies. Hum. Reprod. 1999, 14: 2286–2292.
Van Golde R.J.T., Nap A.W., Tuerlings J.H.A.M., De-Sutter P., Pieters M.H.E.C., Giltay J.C., Kastrop P.M.M., Bijlsma E.K., Braat D.D.M., Kremer J.A.M. Reproductive decisions of men with microdeletions of Y chromosome: the role of genetic counselling. 15th Annual Meeting of the ESHRE. Abstract Book 1. Hum. Reprod. 1999, 14: 94.
Donat R., McNeill A.S., Fetzpatrick D.R., Hargreave T.B. The incidence of cystic fibrosis gene mutation in patients with congenital bilateral absence of the vas deferens in Scotland. Br. J. Urol. 1997, 79: 74–77.
Dean M., Santis G. Heterogenecity in the severity of cystic fibrosis and the role of the CFTR gene mutations. Hum. Genet. 1994, 93: 364–368.
Tournaye H., Devroey P., Liu J., Nagy Z., Lissens W., Van-Steirteghem A. Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: a new effective approach to infertility as a result of congenital bilateral absence of the vas deferens. Fertil. Steril. 1994, 61: 1045–1051.
Oates R.D., Amos J.A. The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J. Androl. 1994, 15: 1–8.
Mercier B., Verlingue C., Lissens W., Silber S.J., Noveli G., Bonduelle M., Audrezet M.P., Ferec C. Is congenital bilateral absence of vas deferens primary form of cystic fibrosis ? Analysis of the CFTR gene in 67 patients. Am. J. Hum. Genet. 1995, 56: 272–277.
Chillon M., Casals T., Mercier B., Bassas L., Lissens W., Silber S., Romey M.C., Ruiz-Romero J., Verlingue C., Claustres M., Nunes V., et al. Mutations in cystic fibrosis gene in patients with congenital absence of the vas deferens. N. Engl. J. Med. 1995, 332: 1475–1480.
Drake M.J., Quinn F.M. Absent vas deferens and ipsilateral multicystic dysplastic kidney in a child. Br. J. Urol. 1996, 77: 756–757.
Augarten A., Yahav Y., Kerem B.S., Halle D., Laufer J., Szeinberg A., Dor J., Mashiach S., Gazit E., Madgar I. Congenital bilateral absence of the vas deferens in the absence of cystic fibrosis. Lancet 1994, 344: 1473–1474.
Nudell D., Castillo M., Turek P.J., Pera R.R. Increased frequency of mutations in DNA from infertile men with meiotic arrest. Hum. Reprod. 2000, 15: 1289–1294.
Zeyneloglu H.B., Baltaci V., Ege S., Haberal A., Batioglu S. Detection of chromosomal abnormalities by fluorescent in-situ hybridization in immotile viable spermatozoa determined by hypo-osmotic sperm swelling test. Hum. Reprod. 2000, 15: 853–856.
Finkelstein S., Mukamel E., Yavetz H., Paz G., Avivi L. Increased rate of nondisjunction in sex cells derived from low quality semen. Hum. Genet. 1998, 102: 129–137.
Martin R.H. The risk of chromosomal abnormalities following ICSI. Hum. Reprod. 1996, 11: 924–925.
Gazvani M.R., Wilson E.D.A., Richmond D.H., Howard P.J., Kingsland C.R., Lewis-Jones D.I. Evaluation of the role of mitotic instability in karyotypically normal men with oligozoospermia. Fertil. Steril. 2000, 73: 51–55.
Kuroki Y., Iwamoto T., Lee J., Yoshiike M., Nozawa S., Nishida T., Ewis A.A, Nakamura H., Toda T., Tokunaga K., Kotliarova S.E., et al. Spermatogenic ability is different among males in different Y chromosome. Iineage. Hum. Genet. 1999, 44: 289–292.
Irvine D.S., Twigg J.P., Gordon E.L., Fulton N., Milne P.A., Aitken R.J. DNA integrity in human spermatozoa: relationships with semen quality. J. Androl. 2000, 21: 33–44.
Chatterjee R., Haines G.A., Perera D.M.D., Goldstone A., Morris I.D. Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum. Reprod. 2000, 15: 762–766.
Griffin D.K., Abruzzo M.A., Millie E.A., Sheean L.A., Feingold E., Sherman S.L., Hassold T.J. Non-disjunction in human sperm: evidence for an effect of increasing paternal age. Hum. Mol. Genet. 1995, 4: 2227–2232.
Tolarova M.M., Harris J.A., Ordway D.E., Vargervik K. Birth prevalence, mutation rate, sex ratio, parent’s age and ethnicity in Apert syndrome. Am. J. Med. Genet. 1997, 72: 394–398.
Linden J.V., Centola G. New American Association of Tissue Banks standards for semen banking. Fertil. Steril. 1997, 68: 597–600.
British Andrology Society. British Andrology Society guidelines for the screening of semen donors for donor insemination (1999). Hum. Reprod. 1999, 14: 1823–1826.
Lansac J., Thepot F., Mayuax M.J. Pregnancy outcome after artificial insemination or IVF with frozen semen donor: a collaborative study of the French CECOS Federation on 21,597 pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 1997, 74: 223–228.
Danan C., Sterberg D., Steirteghem A.V., Cazeneuve C., Duquesnoy P., Besmond C., Goossens M., Lissens W., Amselem S. Evaluation of parental mitochondrial inheritance in neonates born after intracytoplasmic sperm injection. Am. J. Hum. Genet. 1999, 65: 463–473.
Giltay J.C., Kastrop P.M.M., Tuerlings J.H.A.M., Kremer J.A.M., Tiemessen C.H.J., Gerssen-Schoorl K.B.J., van-der-Veen F., De-Vries J., Hordijk R., Hamers G.J.H., Hansson K., et al. Subfertile men with constitutive chromosome abnormalities do not necessarily refrain from intracytoplasmic sperm injection treatment: a follow-up study on 75 Dutch patients. Hum. Reprod. 1999, 14: 318–320.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hargreave, T. Genetically determined male infertility and assisted reproduction techniques. J Endocrinol Invest 23, 697–710 (2000). https://doi.org/10.1007/BF03343796
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343796